McRae Marion E, Rodger Marnie, Bailey Barbara A
Peter Munk Cardiac Centre, Toronto General Hospital, and Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada.
Crit Care Nurse. 2009 Feb;29(1):22-37; quiz 38. doi: 10.4037/ccn2009553.
Minimally invasive valve replacement is limited to bioprosthetic aortic and pulmonary valves for use in very specific populations of patients. Replacement via trans-catheter and transapical techniques should be used only in patients in whom traditional surgical replacement is deemed an unacceptable risk. Nursing management will focus heavily on care for comorbid conditions because of the high-risk nature of the patients in whom these valves will initially be implanted.
微创瓣膜置换术仅限于生物人工主动脉瓣和肺动脉瓣,用于非常特定的患者群体。经导管和经心尖技术置换仅应用于传统手术置换被认为风险不可接受的患者。由于最初植入这些瓣膜的患者具有高风险性质,护理管理将高度侧重于合并症的护理。